9 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18444368 | COMPOSITIONS AND METHODS FOR GENE EDITING | HOLLAND, PAUL J | 1656 | Final Rejection | Feb 16, 2024 |
| 18188406 | ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION | METCALF, MATTHEW CURRAN | 1647 | Non-Final OA | Mar 22, 2023 |
| 18181135 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | BARRERA, IMMACULADA | 1671 | Non-Final OA | Mar 09, 2023 |
| 17934799 | HIGH PURITY gRNA SYNTHESIS PROCESS | ZARA, JANE J | 1637 | Final Rejection | Sep 23, 2022 |
| 17933369 | UNIVERSAL DONOR CELLS | QIAN, CELINE X | 1637 | Non-Final OA | Sep 19, 2022 |
| 17906471 | T-CELL BISPECIFIC BINDING PROTEINS | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | Sep 15, 2022 |
| 17904002 | ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BUNNER, BRIDGET E | 1647 | Non-Final OA | Aug 10, 2022 |
| 17491761 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Final Rejection | Oct 01, 2021 |
| 16488149 | COMPOSITIONS AND METHODS FOR TREATMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)-RELATED DISORDERS | CLARKE, TRENT R | 1651 | Final Rejection | Aug 22, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial